Foresite Capital Management V, LLC
Foresite Capital Management V, LLC reported 9 holdings worth US$289M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Foresite Capital Management V, LLC reported 9 holdings worth US$289M as of Sep 30, 2026. Largest: CG Oncology, Inc., Latigo Biotherapeutics, Inc. and Alumis Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 9
- Value as reported
- US$289M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| CG Oncology, Inc. | 1.08M | US$76.5M | 26.5% |
| Latigo Biotherapeutics, Inc. | 3.56M | US$59.5M | 20.6% |
| Alumis Inc. | 5.9M | US$43.6M | 15.1% |
| Hims & Hers Health, Inc. | 884K | US$26.3M | 9.1% |
| Disc Medicine, Inc. | 374K | US$24.5M | 8.5% |
| Odyssey Therapeutics, Inc. | 730K | US$16.2M | 5.6% |
| Nurix Therapeutics, Inc. | 459K | US$10.9M | 3.8% |
| Eikon Therapeutics, Inc. | 1.32M | US$10.6M | 3.7% |
| Lyell Immunopharma, Inc. | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC